FDA Seeks More Information On Use of Fuzeon With Needle-Free Injector
Roche/Trimeris received an “approvable” letter from FDA for the HIV therapy Fuzeon administered with a needle-free Biojector device.
Roche/Trimeris received an “approvable” letter from FDA for the HIV therapy Fuzeon administered with a needle-free Biojector device.